The group’s principle activities include developing and commercializing of biomaterials that address intra-operative and post-operative complications. The group operates through four segments namely alants, adhesion barriers, internal and external adhesives, and hemostatic agents. The group’s products include Dura seal(R), Spray gel(R), and Xact(TM). The group operates from United States.
